Get the Stockscreener App
75.84
3.13%
2.30
After Hours:
75.73
-0.11
-0.15%
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $75.84, with a volume of 7.32M.
It is up +3.13% in the last 24 hours and up +0.60% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$73.54
Open:
$74.09
24h Volume:
7.32M
Relative Volume:
0.99
Market Cap:
$31.34B
Revenue:
$9.51B
Net Income/Loss:
$2.64B
P/E Ratio:
12.56
EPS:
6.0361
Net Cash Flow:
$2.14B
1W Performance:
-1.85%
1M Performance:
+0.60%
6M Performance:
-40.12%
1Y Performance:
-50.25%
1-Day Range:
$73.01
$75.84
1-Week Range:
$71.45
$79.25
52-Week Range:
$71.45
$160.48
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS vs TAK, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
75.84 | 30.39B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
17.39 | 55.60B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.80 | 43.16B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.52 | 42.81B | 17.53B | 1.58B | 444.18M | 1.3457 |
UTHR
United Therapeutics Corp
|
501.27 | 21.95B | 3.17B | 1.29B | 1.01B | 27.09 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Citigroup | Buy |
| Jan-22-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-21-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-17-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jun-18-25 | Downgrade | Stifel | Buy → Hold |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
Is It Too Late to Buy Zoetis Inc (ZTS) After 3.1% Rally? GF Value Says Undervalued - GuruFocus
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies - Business Wire
Zoetis Inc. (ZTS) Stock Forecasts - Yahoo Finance
Zoetis gets US FDA emergency use nod for treatment for screwworm in dogs - Reuters
Handelsbanken Fonder AB Purchases 21,990 Shares of Zoetis Inc. $ZTS - MarketBeat
The Top 5 Analyst Questions From Zoetis’s Q2 Earnings Call - StockStory
Zoetis Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zoetis Inc (MIL:1ZTS) Stock Price, Trades & News - GuruFocus
Zoetis slides as investors remain focused on softer pet-care demand and competitive pressure - Quiver Quantitative
Zoetis (NYSE:ZTS) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat
Zoetis Inc. (NYSE:ZTS) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Citigroup Lowers Zoetis (NYSE:ZTS) Price Target to $96.00 - MarketBeat
BNP Paribas Exane Issues Pessimistic Forecast for Zoetis (NYSE:ZTS) Stock Price - MarketBeat
ZOETIS INC : BNP PARIBAS CUTS TARGET PRICE TO $110 FROM $146 - Bitget
ZOETIS INC : CITIGROUP CUTS TARGET PRICE TO $96 FROM $112 - Bitget
Citigroup Adjusts Price Target on Zoetis to $96 From $112, Maintains Buy Rating - marketscreener.com
Michael Burry Refreshes Bearish Palantir Trade Even As AI Rally Strains Short Bets - TradingView
Zoetis Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance
Zoetis (NYSE:ZTS) Hits New 52-Week Low Following Analyst Downgrade - MarketBeat
BNP Paribas Adjusts Price Target on Zoetis to $110 From $146, Maintains Outperform Rating - marketscreener.com
Zoetis (ZTS) Looked Like a Winner. What Went Wrong? - Yahoo Finance
5 Stock Picks Last Week From Wall Street's Most Accurate Analysts - Benzinga
Zoetis Inc. (ZTS) Investor Outlook: Analyzing a Potential 43% Upside in the Healthcare Sector - DirectorsTalk Interviews
Zoetis (ZTS) Is Down 5.8% After Cutting 2026 Outlook And Overhauling Leadership Structure - simplywall.st
Deane Retirement Strategies Inc. Purchases Shares of 31,245 Zoetis Inc. $ZTS - MarketBeat
Assenagon Asset Management S.A. Lowers Position in Zoetis Inc. $ZTS - MarketBeat
ZOETIS INC : PIPER SANDLER CUTS TARGET PRICE TO $80 FROM $90 - Bitget
Zoetis Q2 Earnings Call Highlights - MarketBeat
Jacobs & Co. CA Lowers Stock Position in Zoetis Inc. $ZTS - MarketBeat
Maj Invest Holding A S Sells 78,471 Shares of Zoetis Inc. $ZTS - MarketBeat
Seilern Investment Management Ltd Has $33.06 Million Stock Position in Zoetis Inc. $ZTS - MarketBeat
Chemistry Wealth Management LLC Boosts Stake in Zoetis Inc. $ZTS - MarketBeat
Chesley Taft & Associates LLC Sells 17,131 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis (ZTS) Beat Q2 EPS Estimates, Is The Stock A Bargain? - simplywall.st
Zoetis Cut Its 2026 Guide in Q2 Earnings. The Dermatology Lead Is the Reason. - TIKR.com
Rockland Trust Co. Boosts Stock Position in Zoetis Inc. $ZTS - MarketBeat
PensionDanmark Pensionsforsikringsaktieselskab Has $10.58 Million Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Community Trust & Investment Co. Lowers Stake in Zoetis Inc. $ZTS - MarketBeat
Zoetis (ZTS) Stock Sinks After Guidance Cut Deepens Profit Concerns - Sahm
Zoetis (NYSE:ZTS) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
From Freddie Mac to Zoetis: Burry’s Five Buys and Chip Short - Stocktwits
A Look at Zoetis Inc (ZTS) After 6.0% Decline -- GF Value $195.4 - GuruFocus
Zoetis Drops 5.4% After William Blair Downgrades to Market Perform - AlphaStreet
Zoetis Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zoetis nabs GE Health CFO for dual finance chief, COO role - cfodive.com
Zoetis (NYSE:ZTS) Stock Price Down 6.2% on Analyst Downgrade - MarketBeat
JPMorgan Chase & Co. Lowers Zoetis (NYSE:ZTS) Price Target to $115.00 - MarketBeat
Zoetis Names Jay Saccaro to Combined Finance and Operations Role - parsippanyfocus.com
Zoetis (ZTS) Following Earnings And Guidance Cut With A Valuation Question - Yahoo Finance
Zoetis Combines Finance and Operations Under One Executive With Saccaro Appointment - centraljersey.com
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Zoetis Inc Stock (ZTS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bisaro Paul | Director |
May 13 '26 |
Buy |
75.88 |
2,000 |
151,750 |
27,862 |
| MCCALLISTER MICHAEL B | Director |
May 11 '26 |
Buy |
77.76 |
3,000 |
233,273 |
24,524 |
| PECK KRISTIN C | Chief Executive Officer |
Feb 17 '26 |
Option Exercise |
41.83 |
20,000 |
836,600 |
121,337 |
| PECK KRISTIN C | Chief Executive Officer |
Feb 17 '26 |
Sale |
127.05 |
20,000 |
2,540,964 |
101,337 |
2.04%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):